Baxter International IncNYSE:BAX
- LAST PRICE40.2300
- TODAY'S CHANGE (%)-0.1400 (-0.3468%)
- Bid / Lots40.2100/ 16
- Ask / Lots40.2300/ 8
- Open / Previous Close40.1300 / 40.3700
- Day Range
- 52 Week Range
- Volume471,934
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BAX |
|---|---|---|
| 09:32 ET | 19848 | 40.34 |
| 09:34 ET | 8423 | 40.41 |
| 09:36 ET | 14780 | 40.265 |
| 09:38 ET | 13540 | 40.3 |
| 09:39 ET | 7466 | 40.19 |
| 09:41 ET | 11131 | 40.15 |
| 09:43 ET | 6820 | 40.07 |
| 09:45 ET | 3863 | 40.03 |
| 09:48 ET | 11584 | 40.04 |
| 09:50 ET | 8368 | 40.11 |
| 09:52 ET | 7906 | 40.08 |
| 09:54 ET | 3060 | 40.1 |
| 09:56 ET | 9409 | 40.13 |
| 09:57 ET | 4054 | 40.175 |
| 09:59 ET | 4483 | 40.17 |
| 10:01 ET | 5695 | 40.17 |
| 10:03 ET | 2557 | 40.16 |
| 10:06 ET | 7832 | 40.15 |
| 10:08 ET | 5107 | 40.145 |
| 10:10 ET | 3370 | 40.14 |
| 10:12 ET | 10407 | 40.19 |
| 10:14 ET | 4672 | 40.18 |
| 10:15 ET | 4199 | 40.15 |
| 10:17 ET | 6740 | 40.12 |
| 10:19 ET | 10564 | 40.05 |
| 10:21 ET | 12438 | 40.02 |
| 10:24 ET | 4521 | 40.055 |
| 10:26 ET | 5174 | 39.99 |
| 10:28 ET | 4619 | 40.015 |
| 10:30 ET | 5952 | 40.03 |
| 10:32 ET | 3099 | 40.04 |
| 10:33 ET | 10927 | 39.98 |
| 10:35 ET | 3705 | 40.005 |
| 10:37 ET | 8497 | 40.03 |
| 10:39 ET | 5612 | 40 |
| 10:42 ET | 8148 | 39.98 |
| 10:44 ET | 3750 | 40.01 |
| 10:46 ET | 9410 | 40.03 |
| 10:48 ET | 5512 | 40.035 |
| 10:50 ET | 5352 | 39.995 |
| 10:51 ET | 5287 | 40.05 |
| 10:53 ET | 11819 | 40.125 |
| 10:55 ET | 15705 | 40.07 |
| 10:57 ET | 5022 | 40.125 |
| 11:00 ET | 7556 | 40.145 |
| 11:02 ET | 10996 | 40.145 |
| 11:04 ET | 8751 | 40.14 |
| 11:06 ET | 7839 | 40.175 |
| 11:08 ET | 4693 | 40.215 |
| 11:09 ET | 2074 | 40.23 |
Apr 11, 2024
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S., from 8:30AM ET on Thursday Apr 11, 2024 by Dow Jones
8:30AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 10, 2024
Press Release: Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors, from 4:20PM ET on Wednesday Apr 10, 2024 by Dow Jones
4:20PM ET on Wednesday Apr 10, 2024 by Dow JonesBaxter to Host First-Quarter 2024 Financial Results Conference Call for Investors, from 4:15PM ET on Wednesday Apr 10, 2024 by Dow Jones
4:15PM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
DJ Baxter International Is Maintained at Neutral by Citigroup, from 11:43AM ET on Wednesday Apr 03, 2024 by Dow Jones
11:43AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 1, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Baxter International Inc | 20.6B | -266.8x | --- |
STERIS plc | 20.2B | 36.1x | -19.58% |
Zimmer Biomet Holdings Inc | 24.7B | 24.3x | --- |
Align Technology Inc | 21.2B | 45.9x | +3.39% |
Avantor Inc | 16.5B | 62.5x | --- |
Henry Schein Inc | 8.9B | 22.0x | +2.98% |
Company Information
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
Contact Information
- Headquarters
- DF2-1W, ONE BAXTER PKWYDEERFIELD, IL, United States 60015
- Phone
- 847-948-2000
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Jose Almeida
- Chief Financial Officer, Executive Vice President
- Joel Grade
- Chief Human Resource Officer, Executive Vice President
- Jeanne Mason
- Executive Vice President, General Counsel
- David Rosenbloom
- Executive Vice President and Chief Supply Chain Officer
- James Borzi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.6B |
|---|---|
Revenue (TTM) | $14.8B |
Shares Outstanding | 509.3M |
Dividend Yield | 2.88% |
Annual Dividend Rate | 1.1600 USD |
Ex-Dividend Date | 02-29-24 |
Pay Date | 04-01-24 |
Beta | 0.64 |
EPS | $-0.15 |
Book Value | $16.55 |
P/E Ratio | -266.8x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | 17.2x |
Operating Margin | 2.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
